Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QIVc vs Comparator QIV in Children 6 to 47 Months
NCT04074928Phase 3Completed
- Sponsor
- CSL Seqirus
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine (cell-based) in influenza, sponsored by CSL Seqirus. Started Sep 2019; status: completed.
02
Drugs
influenza vaccine (cell-based)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04074928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04074928.